Costa R - Search Results

1

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Costa R, Carneiro BA, Chandra S, Pai SG, Chae YK, Kaplan JB, Garrett HB, Agulnik M, Kopp PA, Giles FJ. Costa R, et al. Drug Des Devel Ther. 2016 Feb 29;10:873-84. doi: 10.2147/DDDT.S93459. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27013865 Free PMC article. Review.

2

Is Personalized Medicine Here?

Carneiro BA, Costa R, Taxter T, Chandra S, Chae YK, Cristofanilli M, Giles FJ. Carneiro BA, et al. Among authors: costa r. Oncology (Williston Park). 2016 Apr;30(4):293-303, 307. Oncology (Williston Park). 2016. PMID: 27085327 Free article. Review.

3

The challenge of developmental therapeutics for adrenocortical carcinoma.

Costa R, Carneiro BA, Tavora F, Pai SG, Kaplan JB, Chae YK, Chandra S, Kopp PA, Giles FJ. Costa R, et al. Oncotarget. 2016 Jul 19;7(29):46734-46749. doi: 10.18632/oncotarget.8774. Oncotarget. 2016. PMID: 27102148 Free PMC article. Review.

4

FGFR3-TACC3 fusion in solid tumors: mini review.

Costa R, Carneiro BA, Taxter T, Tavora FA, Kalyan A, Pai SA, Chae YK, Giles FJ. Costa R, et al. Oncotarget. 2016 Aug 23;7(34):55924-55938. doi: 10.18632/oncotarget.10482. Oncotarget. 2016. PMID: 27409839 Free PMC article. Review.

5

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.

Chae YK, Davis AA, Carneiro BA, Chandra S, Mohindra N, Kalyan A, Kaplan J, Matsangou M, Pai S, Costa R, Jovanovic B, Cristofanilli M, Platanias LC, Giles FJ. Chae YK, et al. Among authors: costa r. Oncotarget. 2016 Oct 4;7(40):65364-65373. doi: 10.18632/oncotarget.11692. Oncotarget. 2016. PMID: 27588476 Free PMC article.

6

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials.

Costa R, Carneiro BA, Agulnik M, Rademaker AW, Pai SG, Villaflor VM, Cristofanilli M, Sosman JA, Giles FJ. Costa R, et al. Oncotarget. 2017 Jan 31;8(5):8910-8920. doi: 10.18632/oncotarget.13315. Oncotarget. 2017. PMID: 27852042 Free PMC article. Review.

7

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Costa R, Santa-Maria CA, Rossi G, Carneiro BA, Chae YK, Gradishar WJ, Giles FJ, Cristofanilli M. Costa R, et al. Oncotarget. 2017 Feb 14;8(7):12417-12432. doi: 10.18632/oncotarget.13778. Oncotarget. 2017. PMID: 27926493 Free PMC article. Review.

8

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.

Chae YK, Ranganath K, Hammerman PS, Vaklavas C, Mohindra N, Kalyan A, Matsangou M, Costa R, Carneiro B, Villaflor VM, Cristofanilli M, Giles FJ. Chae YK, et al. Among authors: costa r. Oncotarget. 2017 Feb 28;8(9):16052-16074. doi: 10.18632/oncotarget.14109. Oncotarget. 2017. PMID: 28030802 Free PMC article. Review.

9

Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

Costa R, Shah AN, Santa-Maria CA, Cruz MR, Mahalingam D, Carneiro BA, Chae YK, Cristofanilli M, Gradishar WJ, Giles FJ. Costa R, et al. Cancer Treat Rev. 2017 Feb;53:111-119. doi: 10.1016/j.ctrv.2016.12.010. Epub 2017 Jan 5. Cancer Treat Rev. 2017. PMID: 28104566 Review.

10

Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

Costa R, Carneiro BA, Wainwright DA, Santa-Maria CA, Kumthekar P, Chae YK, Gradishar WJ, Cristofanilli M, Giles FJ. Costa R, et al. Ann Oncol. 2017 Jan 1;28(1):44-56. doi: 10.1093/annonc/mdw532. Ann Oncol. 2017. PMID: 28177431 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,280 results

Search Page